Divalproex Sodium Capsule, Coated Pellets
Product Images NDC 65841-639

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 65841-639). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

27ab558b E2e6 4720 A700 63633efbfb76 05

27ab558b E2e6 4720 A700 63633efbfb76 05
This is a prescription drug called Divalproex Sodium Delayed-Release Capsules, USP. The capsules contain valproic acid and are dispensed to patients in a tightly sealed container accompanied by a medication guide. The usual dosage can be swallowed whole or placed on food for administration as per the package insert. The drug should be stored at a controlled room temperature between 20°C and 25°C. The manufacturer is Cadia Healthcare Ltd. from Ahmedabad, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.